Total Payments
$24,754
2024 Payments
$485.80
Companies
8
Transactions
40
Medicare Patients
5,443
Medicare Billing
$432,219
Payment Breakdown by Category
Other$21,150 (85.4%)
Travel$1,955 (7.9%)
Food & Beverage$1,602 (6.5%)
Education$47.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,150 | 7 | 85.4% |
| Travel and Lodging | $1,955 | 8 | 7.9% |
| Food and Beverage | $1,602 | 23 | 6.5% |
| Education | $47.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $23,526 | 20 | $0 (2017) |
| ABBVIE INC. | $463.92 | 8 | $0 (2024) |
| Kyowa Kirin, Inc. | $429.87 | 6 | $0 (2024) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $109.01 | 1 | $0 (2024) |
| Boston Scientific Corporation | $46.40 | 2 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $29.96 | 1 | $0 (2023) |
| Musculoskeletal Transplant Foundation Inc. | $23.72 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $485.80 | 11 | Kyowa Kirin, Inc. ($199.85) |
| 2023 | $259.98 | 4 | Kyowa Kirin, Inc. ($230.02) |
| 2022 | $22.92 | 1 | Boston Scientific Corporation ($22.92) |
| 2021 | $101.39 | 1 | AbbVie Inc. ($101.39) |
| 2019 | $110.76 | 1 | AbbVie, Inc. ($110.76) |
| 2018 | $247.03 | 2 | GENZYME CORPORATION ($125.00) |
| 2017 | $23,526 | 20 | Actelion Pharmaceuticals US, Inc. ($23,526) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $97.07 | General |
| Category: Monoclonal Antibody | ||||||
| 08/07/2024 | Musculoskeletal Transplant Foundation Inc. | — | Food and Beverage | In-kind items and services | $23.72 | General |
| 07/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $109.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.48 | General |
| 05/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 01/10/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $79.28 | General |
| Category: Monoclonal Antibody | ||||||
| 10/28/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $29.96 | General |
| 07/21/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 07/20/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $121.16 | General |
| Category: Monoclonal Antibody | ||||||
| 07/19/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $85.36 | General |
| Category: Monoclonal Antibody | ||||||
| 02/09/2022 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: LUX-Dx_CRM | ||||||
| 07/21/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $101.39 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $110.76 | General |
| Category: Immunology | ||||||
| 12/05/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $122.03 | General |
| Category: Immunology | ||||||
| 11/03/2017 | Actelion Pharmaceuticals US, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 11/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 11/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $367.97 | General |
| 11/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $302.38 | General |
| 11/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $148.40 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,211 | 1,775 | $474,349 | $105,745 |
| 2022 | 15 | 1,490 | 2,051 | $513,039 | $119,706 |
| 2021 | 19 | 1,486 | 2,019 | $519,078 | $128,022 |
| 2020 | 15 | 1,256 | 1,697 | $389,449 | $78,746 |
Total Patients
5,443
Total Services
7,542
Medicare Billing
$432,219
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 292 | 327 | $75,864 | $20,020 | 26.4% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 25 | 208 | $78,624 | $19,317 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 211 | $72,584 | $18,452 | 25.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 175 | 194 | $70,616 | $15,641 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 138 | 163 | $63,081 | $10,850 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 104 | 119 | $16,660 | $4,726 | 28.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 94 | 116 | $30,972 | $4,338 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $17,056 | $3,891 | 22.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 49 | 91 | $19,019 | $3,537 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $10,410 | $2,139 | 20.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $6,804 | $1,211 | 17.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 65 | 225 | $9,900 | $1,138 | 11.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 14 | $2,604 | $457.96 | 17.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 31 | $155.00 | $26.36 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 228 | 279 | $95,976 | $26,115 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 343 | 397 | $92,104 | $24,520 | 26.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 208 | 227 | $82,628 | $18,178 | 22.0% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 26 | 132 | $32,616 | $12,499 | 38.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 130 | 147 | $56,889 | $9,413 | 16.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 136 | 161 | $42,987 | $6,697 | 15.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $27,183 | $6,075 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $18,391 | $3,376 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 70 | $9,800 | $2,999 | 30.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 38 | 61 | $12,749 | $2,393 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 27 | $9,288 | $2,029 | 21.8% |
About Dr. Heather Goff, MD
Dr. Heather Goff, MD is a Dermatology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992853154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heather Goff, MD has received a total of $24,754 in payments from pharmaceutical and medical device companies, with $485.80 received in 2024. These payments were reported across 40 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,150).
As a Medicare-enrolled provider, Goff has provided services to 5,443 Medicare beneficiaries, totaling 7,542 services with total Medicare billing of $432,219. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Dallas, TX
- Active Since 01/06/2007
- Last Updated 01/30/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1992853154
Products in Payments
- Poteligeo (Drug) $429.87
- Humira (Biological) $232.79
- SKYRIZI (Biological) $129.74
- DUPIXENT (Drug) $125.00
- DUPIXENT (Biological) $109.01
- HUMIRA (Biological) $101.39
- LUX-Dx Insertable Cardiac Monitor (Device) $22.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Dallas
Dr. Jennifer Cather, M.d, M.D
Dermatology — Payments: $1.8M
Dermatology $1.8M
Dr. Joseph Merola, M.d., M.m.sc, M.D., M.M.SC
Dermatology — Payments: $1.7M
Dermatology $1.7M
Dr. Martin Menter, Md, MD
Dermatology — Payments: $1.1M
Dermatology $1.1M
Dr. So Yeon Paek, M.d, M.D
Dermatology — Payments: $637,453
Dermatology $637,453
Dr. William Abramovits, M.d, M.D
Dermatology — Payments: $634,225
Dermatology $634,225
Dr. Ross Radusky, M.d, M.D
Dermatology — Payments: $598,043
Dermatology $598,043